Drugmakers race to find Alzheimer's treatment:

07/11/2012 | Bloomberg

Both Eli Lilly & Co. and a consortium comprising Johnson & Johnson, Pfizer and Elan have potential Alzheimer's disease drugs in clinical trials. If successful, the drugs could be blockbusters and could lower the cost of caring for patients with the disease, analysts say. Even if the current trials are not successful, the drugmakers might try testing the drugs as preventives in people with biomarkers but no symptoms.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX